- Home
- MSB vs STXS Comparison
MSB vs STXS Comparison
Compare MSB & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSB
- STXS
- Stock Information
- Founded
- MSB 1961
- STXS 1990
- Country
- MSB United States
- STXS United States
- Employees
- MSB N/A
- STXS N/A
- Industry
- MSB Metal Mining
- STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MSB Basic Materials
- STXS Health Care
- Exchange
- MSB Nasdaq
- STXS Nasdaq
- Market Cap
- MSB 320.9M
- STXS 275.9M
- IPO Year
- MSB N/A
- STXS 2004
- Fundamental
- Price
- MSB $34.14
- STXS $2.91
- Analyst Decision
- MSB
- STXS
- Analyst Count
- MSB 0
- STXS 0
- Target Price
- MSB N/A
- STXS N/A
- AVG Volume (30 Days)
- MSB 37.7K
- STXS 539.8K
- Earning Date
- MSB 01-01-0001
- STXS 11-11-2025
- Dividend Yield
- MSB 19.85%
- STXS N/A
- EPS Growth
- MSB 425.34
- STXS N/A
- EPS
- MSB 7.07
- STXS N/A
- Revenue
- MSB $25,011,439.00
- STXS $31,806,000.00
- Revenue This Year
- MSB N/A
- STXS $30.98
- Revenue Next Year
- MSB N/A
- STXS $49.86
- P/E Ratio
- MSB $4.83
- STXS N/A
- Revenue Growth
- MSB 4.81
- STXS 33.94
- 52 Week Low
- MSB $22.24
- STXS $1.54
- 52 Week High
- MSB $37.00
- STXS $3.59
- Technical
- Relative Strength Index (RSI)
- MSB 55.18
- STXS 43.91
- Support Level
- MSB $35.01
- STXS $2.95
- Resistance Level
- MSB $36.69
- STXS $3.15
- Average True Range (ATR)
- MSB 1.63
- STXS 0.13
- MACD
- MSB 0.08
- STXS -0.03
- Stochastic Oscillator
- MSB 57.40
- STXS 6.37
About MSB Mesabi Trust
Mesabi Trust operates as a royalty trust in the United States. The company is involved in the conservation and protection of its assets. The company's principally wholly-owned segment is the iron ore mining segment, which generates income from the Peter Mitchell Mine, an iron mine located near Babbitt, Minnesota, at the eastern end of the Mesabi Iron Range.
About STXS Stereotaxis Inc.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.